🇺🇸 FDA
Pipeline program

Armodafinil

C10953/4030

Approved small_molecule completed

Quick answer

Armodafinil for Excessive Sleepiness is a Approved program (small_molecule) at Teva Pharma GmbH with 3 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Excessive Sleepiness
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials